ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.727,20
0,48%
S&P 500
6.068,62
0,49%
Dow Jones
44.968,72
0,57%
Euro vs US Dollar
1,04237
-0,01%
Bitcoin
105.602,78
1,79%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Lipella Pharmaceuticals Inc (LIPO) Börsenkurse

Lipella Pharmaceuticals Inc

Lipella Pharmaceuticals Inc (LIPO)

NASDAQ
2,69
-0,02
( -0,74% )
Aktualisiert: 19:30:04
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
2,69
Gebot
2,70
Fragen
2,76
Volumen
13.447
2,60 Tagesbereich 2,79
2,21 52-Wochen-Bereich 12,00
Marktkapitalisierung
3,252M
Handelsende
2,71
Handelsbeginn
2,66
Letzte Trade
10
@
2.76
Letzter Handelszeitpunkt
19:46:23
Finanzvolumen
US$ 36.208
VWAP
2,6926
Durchschnittliches Volumen (3 Mio.)
152.305
Ausgegebene Aktien
1.208.919
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,70
Gewinn pro Aktie (EPS)
-3,82
Erlöse
450k
Nettogewinn
-4,62M

Über Lipella Pharmaceuticals Inc

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinic... Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.lipella.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Lipella Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LIPO. The last closing price for Lipella Pharmaceuticals was US$2,71. Over the last year, Lipella Pharmaceuticals shares have traded in a share price range of US$ 2,21 to US$ 12,00.

Lipella Pharmaceuticals currently has 1.208.919 shares in issue. The market capitalisation of Lipella Pharmaceuticals is US$3,28 million. Lipella Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.70.

LIPO Neueste Nachrichten

Weitere Nachrichten

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

24 Januar 2025
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

24 Januar 2025
Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

18 Januar 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Januar 2025
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

16 Januar 2025
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

16 Januar 2025
Edgar (US Regulatory)

Form 8-K - Current report

13 Januar 2025
Edgar (US Regulatory)

Spartan Capital Securities, LLC Serves as Sole Placement Agent in Lipella Pharmaceuticals Inc.’s $875,500 Private Placement

New York, NY, Jan. 10, 2025 (GLOBE NEWSWIRE) --  Spartan Capital Securities, LLC, a premier investment banking firm, is pleased to announce the successful completion of two private placements...

10 Januar 2025
GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities

07 Januar 2025
Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933

07 Januar 2025
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.23-7.876712328772.922.952.6295662.76802591CS
4-0.43-13.78205128213.123.72.6557393.10730404CS
120.0180.6736526946112.6723.72.211523052.95766688CS
26-3.5284-56.74128393166.21847.74962.217120033.83249575CS
52-5.4804-67.07627533548.1704122.2111593446.12808902CS
156-53.47-95.210113960156.1661.762.2176369310.16281959CS
260-53.47-95.210113960156.1661.762.2176369310.16281959CS

LIPO - Frequently Asked Questions (FAQ)

What is the current Lipella Pharmaceuticals share price?
The current share price of Lipella Pharmaceuticals is US$ 2,69
How many Lipella Pharmaceuticals shares are in issue?
Lipella Pharmaceuticals has 1.208.919 shares in issue
What is the market cap of Lipella Pharmaceuticals?
The market capitalisation of Lipella Pharmaceuticals is USD 3,28M
What is the 1 year trading range for Lipella Pharmaceuticals share price?
Lipella Pharmaceuticals has traded in the range of US$ 2,21 to US$ 12,00 during the past year
What is the PE ratio of Lipella Pharmaceuticals?
The price to earnings ratio of Lipella Pharmaceuticals is -0,7
What is the cash to sales ratio of Lipella Pharmaceuticals?
The cash to sales ratio of Lipella Pharmaceuticals is 7,23
What is the reporting currency for Lipella Pharmaceuticals?
Lipella Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Lipella Pharmaceuticals?
The latest annual turnover of Lipella Pharmaceuticals is USD 450k
What is the latest annual profit for Lipella Pharmaceuticals?
The latest annual profit of Lipella Pharmaceuticals is USD -4,62M
What is the registered address of Lipella Pharmaceuticals?
The registered address for Lipella Pharmaceuticals is 108 WEST 13TH STREET, WILMINGTON, DELAWARE, 19801
What is the Lipella Pharmaceuticals website address?
The website address for Lipella Pharmaceuticals is www.lipella.com
Which industry sector does Lipella Pharmaceuticals operate in?
Lipella Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
FOXXFoxx Development Holdings Inc
US$ 10,27
(255,36%)
26,01M
AMODAlpha Modus Holdings Inc
US$ 3,661
(137,73%)
115,23M
TECXTectonic Therapeutic Inc
US$ 50,45
(96,15%)
4,4M
ACONAclarion Inc
US$ 16,15
(75,31%)
2,54M
ATHEAlterity Therapeutics Limited
US$ 4,51
(54,98%)
20,41M
CLEUChina Liberal Education Holdings Ltd
US$ 0,2087
(-97,31%)
192,79M
CRGXCARGO Therapeutics Inc
US$ 3,391
(-74,29%)
17,22M
EVTVEnvirotech Vehicles Inc
US$ 0,38
(-43,03%)
3,23M
IRWDIronwood Pharmaceuticals Inc
US$ 2,2791
(-38,73%)
7,29M
ZKINZK International Group Co Ltd
US$ 0,3011
(-37,98%)
2,13M
NVDANVIDIA Corporation
US$ 119,605
(-3,31%)
222,95M
CLEUChina Liberal Education Holdings Ltd
US$ 0,2077
(-97,32%)
192,79M
MGOLMGO Global Inc
US$ 0,1243
(22,22%)
146,46M
AMODAlpha Modus Holdings Inc
US$ 3,661
(137,73%)
115,23M
SPGCSacks Parente Golf Inc
US$ 0,876
(48,47%)
108,23M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
LIPO
Lipella Pharmaceuticals
USOTC
IVDN
Innovative Designs (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten